Can higher doses always be expected to give better results
"It's amazing, everybody should try it if they're trying to lose weight," Wood said
The most commonly reported side effects in retatrutide clinical trials have been gastrointestinal, including nausea, vomiting, diarrhea, constipation, abdominal discomfort, and decreased appetite
As per estimates, the prevalence of MAFLD among adults in general ranges from 25 to 30%, while the occurrence of underlying nonalcoholic steatohepatitis (NASH) is estimated to be between 3% and 6%
Its worth noting that because retatrutide targets three hormone pathways instead of one or two, some people in trials experienced more pronounced digestive side effects compared to other weight loss medications
Direct mechanisms of tirzepatide on cardiovascular health Although the precise mechanism by which tirzepatide could benefit HF is not known, several potential pathways have been suggested: Anti-inflammatory effects Patients with T2DM experience increased levels of hyperinsulinemia, hyperglycemia, and insulin resistance
